The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
about
CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo.Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13-ETA' and the bispecific scFv [13xds16].Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?Immunoglobulin A: magic bullet or Trojan horse?Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteins.
P2860
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
@en
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
@nl
type
label
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
@en
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
@nl
prefLabel
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
@en
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
@nl
P2093
P2860
P50
P356
P1476
The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
@en
P2093
Bernhard Stockmeyer
Christian Cremer
Christoph Stein
Dmitrij Hristodorov
Edgar Jost
Hannes Brehm
Judith Niesen
Radoslav Mladenov
Rainer Fischer
P2860
P304
P356
10.1002/IJC.29628
P577
2015-06-04T00:00:00Z